• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea.

作者信息

Fu Jun-Ling, Wang Tong, Xiao Xin-Hua

机构信息

Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

出版信息

Chin Med J (Engl). 2019 Apr 5;132(7):846-848. doi: 10.1097/CM9.0000000000000147.

DOI:10.1097/CM9.0000000000000147
PMID:30897598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6595857/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a9/6595857/52ef37be52db/cm9-132-846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a9/6595857/52ef37be52db/cm9-132-846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a9/6595857/52ef37be52db/cm9-132-846-g001.jpg

相似文献

1
Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea.磺脲类药物成功治疗复发的6q24相关短暂性新生儿糖尿病
Chin Med J (Engl). 2019 Apr 5;132(7):846-848. doi: 10.1097/CM9.0000000000000147.
2
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.成功用磺酰脲类药物治疗因 KCNJ11 新突变导致的新生儿糖尿病的新生儿。
Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5.
3
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.KCNJ11 基因突变致新生儿糖尿病患者磺脲类药物长期治疗的有效性和安全性：一项国际队列研究。
Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4.
4
[Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].格列吡嗪，一种治疗糖尿病的新型磺脲类药物
Prensa Med Mex. 1973 May-Jun;38(5):211-4.
5
[Effect of sulfanilamide preparations on the blood coagulation system in patients with diabetes mellitus].[磺胺类制剂对糖尿病患者血液凝固系统的影响]
Ter Arkh. 1974;46(10):53-5.
6
[Treatment of diabetes mellitus with glibornurid].用格列波脲治疗糖尿病
Minerva Med. 1973 Oct 24;64(75):3900-6.
7
[Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus].[口服降糖药治疗糖尿病的适应证及局限性]
Cah Med. 1972 Nov 15;13(14):999-1006.
8
[Oral hypoglycemic therapy of diabetes mellitus].[糖尿病的口服降糖治疗]
Minerva Med. 1976 Jan 21;67(3):208-15.
9
[Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].[新型磺脲类药物格列吡嗪治疗糖尿病的评估]
Minerva Med. 1973 Oct 10;64(71):3725-31.
10
[Therapy of diabetes in adults using Glibornurid. Results and clinical studies].[使用格列本脲治疗成人糖尿病。结果与临床研究]
Dtsch Med Wochenschr. 1973 May 4;98(18):915-9. doi: 10.1055/s-0028-1106931.

引用本文的文献

1
Successful Transition to Sulfonylurea for Relapsed Monogenic Diabetes Due to Rare 6q23.3 Duplication.因罕见的6q23.3重复导致复发性单基因糖尿病成功过渡至磺脲类药物治疗。
JCEM Case Rep. 2024 Oct 16;2(10):luae180. doi: 10.1210/jcemcr/luae180. eCollection 2024 Oct.
2
Precision treatment of beta-cell monogenic diabetes: a systematic review.β细胞单基因糖尿病的精准治疗：一项系统综述
Commun Med (Lond). 2024 Jul 18;4(1):145. doi: 10.1038/s43856-024-00556-1.
3
Wolcott-Rallison Syndrome, a Rare Cause of Permanent Diabetes Mellitus in Infants-Case Report.

本文引用的文献

1
Chromosome 6q24-related diabetes mellitus.6号染色体q24相关的糖尿病
Clin Pediatr Endocrinol. 2018;27(2):59-65. doi: 10.1297/cpe.27.59. Epub 2018 Apr 13.
2
Successful off-label sulfonylurea treatment of neonatal diabetes mellitus due to chromosome 6 abnormalities.因 6 号染色体异常导致的新生儿糖尿病经磺酰脲类药物成功治疗。
Pediatr Diabetes. 2018 Jun;19(4):663-669. doi: 10.1111/pedi.12635. Epub 2018 Mar 4.
3
Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.磺脲类药物治疗具有异质遗传背景的新生儿糖尿病患儿。
沃尔科特-拉利森综合征，婴儿永久性糖尿病的罕见病因——病例报告
Pediatr Rep. 2023 Oct 16;15(4):608-616. doi: 10.3390/pediatric15040056.
4
Systematic Review of Treatment of Beta-Cell Monogenic Diabetes.β细胞单基因糖尿病治疗的系统评价
medRxiv. 2023 Sep 22:2023.05.12.23289807. doi: 10.1101/2023.05.12.23289807.
5
Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus?第二代测序技术能否识别出已记录的新生儿糖尿病遗传标记？
Heliyon. 2021 Aug 30;7(9):e07903. doi: 10.1016/j.heliyon.2021.e07903. eCollection 2021 Sep.
6
Monogenic diabetes: a gateway to precision medicine in diabetes.单基因糖尿病：糖尿病精准医学的切入点。
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI142244.
7
Severe Dental Disease as a Presenting Sign of Relapsed 6q24-Related Transient Neonatal Diabetes Mellitus.严重牙病作为6q24相关复发性短暂性新生儿糖尿病的首发症状
Case Rep Endocrinol. 2020 Nov 16;2020:8828516. doi: 10.1155/2020/8828516. eCollection 2020.
8
CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.CRISPR/Cas9 表观基因组编辑在罕见印记疾病中的应用：综述。
Cells. 2020 Apr 16;9(4):993. doi: 10.3390/cells9040993.
J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):877-84. doi: 10.1515/jpem-2014-0429.
4
Relapsing 6q24-related transient neonatal diabetes mellitus successfully treated with a dipeptidyl peptidase-4 inhibitor: a case report.用二肽基肽酶-4抑制剂成功治疗复发性6q24相关短暂性新生儿糖尿病：一例报告
Pediatr Diabetes. 2014 Dec;15(8):606-10. doi: 10.1111/pedi.12123. Epub 2014 Feb 19.
5
Neonatal diabetes mellitus: a model for personalized medicine.新生儿糖尿病：个性化医学的典范。
Trends Endocrinol Metab. 2010 Aug;21(8):464-72. doi: 10.1016/j.tem.2010.03.004. Epub 2010 Apr 29.